Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 369.00
Bid: 369.00
Ask: 371.00
Change: 5.00 (1.37%)
Spread: 2.00 (0.542%)
Open: 381.50
High: 381.50
Low: 369.00
Prev. Close: 364.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

24 Nov 2009 07:00

RNS Number : 9500C
Lupus Capital PLC
24 November 2009
 



Lupus Capital plc

("Lupus" or the "Company")

Board Changes: Jamie Pike appointed Chairman

Lupus Capital plc, the security and residential products and marine breakaway couplings group, announces the appointment of Jamie Pike as Non-Executive Chairman with immediate effect.

Michael Jackson, who became Non-Executive Chairman on 1 July 2009, will revert to being a Non-Executive Director of the Company, also with immediate effect.

Michael Jackson commented:

"Jamie has an outstanding track record and extensive public company experience across a range of UK and international businesses. We are pleased that we have been able to secure someone of such a high calibre and who will bring to Lupus a reputation for incisive strategic and operational capability."

Jamie Pike commented:

"I am delighted to be joining the Board. Whilst Lupus has faced a number of distractions over the last few monthsI believe everyone across the business has remained focused on strengthening the Company's financial and operational positions. I look forward to leading the Company into the next phase of its development."

24 November 2009

Enquiries

Collins Stewart Europe Limited  Tel: +44 (0)20 7523 8350

Mark Dickenson / Tom Hulme

College Hill Tel: +44 (0)20 7457 2020

Mark Garraway / Gareth David

  NOTES TO EDITORS

Jamie Pike

Jamie Pike was Chief Executive of Foseco plcan international business serving the foundry and steel making industries, until its acquisition by Cookson Group plc in April 2008He led the buy-out of Foseco from Burmah Castrol in 2001, which culminated in flotation on the main market in 2005. 

Mr Pike, who is also Chairman of RPC Group PLC, MBA Polymers Inc. and the Defence Support Group, was educated at Oxford, holds an MBA from INSEAD and is a Member of the Institute of Mechanical Engineers.

His early career was as a consultant with Bain and Co and A T Kearney before joining Burmah Castrol in 1991. He rose to Chief Executive of Burmah Castrol Chemicals before leading the Foseco buy-out. He has previously been a Non-Executive Director of two FTSE 250 companies, RMC Group plc and Kelda Group plc. In addition, between 2001 and 2007 he was a non-executive member of the governing Board of the Army Training and Recruitment Agency which is responsible for all individual soldier training in the Army.  

Remuneration

Mr Pike's remuneration will be £90,000 per annum. Whilst he is contracted to serve at least four days per month, Mr Pike's time commitment will vary depending on the needs of the business. In particular, it is expected that he will spend significantly more time on Lupus business in the immediate period following his appointment.

Share Purchase

Mr Pike has confirmed that he intends to acquire shares in the Company on the basis of being a long-term shareholder in the business. 

Further information required by Rule 17 and Schedule 2(g) of the AIM Rules for Companies

James ("Jamie") Robert Provan Pike (age 54)

Present directorships and/or partnerships:

RPC Group Plc: Non-Executive Chairman since July 2008

MBA Polymers Inc: Non-Executive Chairman since August 2008

The Defence Support Group: Non-Executive Chairman since September 2006

Former directorships and/or partnerships (within the last five years):

Foseco plc: Chief Executive Officer April 2005 to April 2008

RMC Group plc: Non-Executive Director June 2002 to February 2006

As at the date of his appointment as a director of the Company, Mr. Pike did not own any ordinary shares in Lupus.

No further disclosures are required under Schedule 2(g) of the AIM Rules for Companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABJBFTMMITBTL
Date   Source Headline
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution
6th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNotice of Results
28th Dec 20223:53 pmRNSHolding(s) in Company
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.